Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Bristol-Myers Squibb Company PFD CONV 2 BMYMP OTC

Other OTC • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
45/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) has 12 identified peers for comparison in the Healthcare sector. Peers include ALPMF, ALPMY, AZN, AZNCF, CHGCY, DSKYF and others.

People Also View

RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 RHHVF
RHHVF
Roche Holding AG
$403.29
+8.69%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 AZNCF
AZNCF
AstraZeneca PLC
$189.90
-1.35%
 GSK
GSK
GSK plc
$59.18
+0.41%
 SNY
SNY
Sanofi
$47.64
+1.45%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message